GlassScriptPhysician profile
Grodonoff Nelson
NPI 1912213935
$10,779.45
in general payments reported to CMS, 2019-2025
43 companies · $1,825 in 2025
The $1,825 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,448 · 2020: $774 · 2021: $997 · 2022: $1,464 · 2023: $1,761 · 2024: $1,509 · 2025: $1,825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,082 · Education: $13.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,082.14 |
| Education | $13.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,930.73 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,774.57 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $1,075.98 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amarin Pharma, INC. | $692.32 | 2019-2023 | |
| Pfizer INC. | $653.43 | 2019-2025 | |
| Abbvie INC. | $561.12 | 2021-2025 | |
| Glaxosmithkline, LLC. | $557.31 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $500.70 | 2019-2025 | Veozah, Myrbetriq |
| Medtronic, INC. | $327.49 | 2022-2023 | Kyphon Express II Kyphopak Tray |
| Boehringer Ingelheim Pharmaceuticals, INC. | $305.32 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $253.54 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $246.27 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $215.85 | 2019-2023 | |
| Amgen INC. | $178.78 | 2019-2025 | Repatha, Otezla, Evenity |
| Teva Pharmaceuticals USA, INC. | $176.16 | 2019-2024 | Ajovy |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grodonoff Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.